WY14,643, a PPARα ligand, attenuates expression of anti-glomerular basement membrane disease

Clinical and Experimental Immunology

Volumn 150, Issue 2, 2007, Pages 386-396

  Archer, D C ^a   Frkanec, J T ^a   Cromwell, J ^a   Clopton, P ^a   Cunard, R ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Anti glomerular basement membrane disease; Fibrates; Glomerulonephritis; MCP 1; Peroxisome proliferator activated receptor

Indexed keywords

CHEMOKINE; COLLAGEN TYPE 4; FREUND ADJUVANT; GAMMA INTERFERON; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G2C; LIGAND; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; UNCLASSIFIED DRUG; CCL2 PROTEIN, MOUSE; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; PEROXISOME PROLIFERATOR; PYRIMIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; ATTENUATION; C57BL 6 MOUSE; CELL COUNT; CLINICAL EVALUATION; CONTROLLED STUDY; FEEDING; FOOD; GENE EXPRESSION; GLOMERULOPATHY; GLOMERULUS BASEMENT MEMBRANE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; KIDNEY CELL; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEINURIA; SERUM; SPLEEN CELL; TH2 CELL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DISEASE COURSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GLOMERULONEPHRITIS; HUMAN; IMMUNOLOGY; KIDNEY; METABOLISM; PATHOLOGY; SPLEEN;

ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; CHEMOKINE CCL2; CYTOKINES; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; GLOMERULAR BASEMENT MEMBRANE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LIGANDS; MICE; MICE, INBRED C57BL; PEROXISOME PROLIFERATORS; PROTEINURIA; PYRIMIDINES; RNA, MESSENGER; SPLEEN;

EID: 35349024872     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03505.x     Document Type: Article

References (52)

1. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha-beta, and -gamma in the adult rat. Endocrinology 1996 137 : 354 66.
2. Issemann I, Prince RA, Tugwood JD, Green S. The peroxisome proliferator-activated receptor: retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J Mol Endocrinol 1993 11 : 37 47.
3. Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 2000 14 : 121 41.
4. Rubins HB, Robins SJ, Collins D et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999 341 : 410 18.
5. Cunard R. The potential use of PPARalpha agonists as immunosuppressive agents. Curr Opin Invest Drugs 2005 6 : 467 72.
6. Cunard R, Ricote M, DiCampli D et al. Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors. J Immunol 2002 168 : 2795 802.
7. Cunard R, DiCampli D, Archer DC et al. WY14,643, a PPAR alpha ligand, has profound effects on immune responses in vivo. J Immunol 2002 169 : 6806 12.
8. Bolton WK, Tucker FL, Sturgill BC. New avian model of experimental glomerulonephritis consistent with mediation by cellular immunity. Nonhumorally mediated glomerulonephritis in chickens. J Clin Invest 1984 73 : 1263 76.
9. Kalluri R, Danoff TM, Okada H, Neilson EG. Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice. J Clin Invest 1997 100 : 2263 75.
10. Wu J, Hicks J, Ou C, Singleton D, Borillo J, Lou YH. Glomerulonephritis induced by recombinant collagen IV alpha 3 chain noncollagen domain 1 is not associated with glomerular basement membrane antibody: a potential T cell-mediated mechanism. J Immunol 2001 167 : 2388 95.
11. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 2003 348 : 2543 56.
12. Hopfer H, Maron R, Butzmann U, Helmchen U, Weiner HL, Kalluri R. The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease in mice. FASEB J 2003 17 : 860 8.
13. Neilson EG, Kalluri R, Sun MJ et al. Specificity of Goodpasture autoantibodies for the recombinant noncollagenous domains of human type IV collagen. J Biol Chem 1993 268 : 8402 5.
14. Luo AM, Fox JW, Chen L, Bolton WK. Synthetic peptides of Goodpasture's antigen in antiglomerular basement membrane nephritis in rats. J Lab Clin Med 2002 139 : 303 10.
15. Dean EG, Wilson GR, Li M et al. Experimental autoimmune Goodpasture's disease: a pathogenetic role for both effector cells and antibody in injury. Kidney Int 2005 67 : 566 75.
16. Lehr HA, Mankoff DA, Corwin D, Santeusanio G, Gown AM. Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 1997 45 : 1559 65.
17. Hume DA, Gordon S. Mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Identification of resident macrophages in renal medullary and cortical interstitium and the juxtaglomerular complex. J Exp Med 1983 157 : 1704 9.
18. Martin RM, Lew AM. Is IgG2a a good Th1 marker in mice? Immunol Today 1998 19 : 49.
19. Wang Y, Chen J, Chen L, Tay YC, Rangan GK, Harris DC. Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 1997 8 : 1537 45.
20. Portilla D, Dai G, Peters JM, Gonzalez FJ, Crew MD, Proia AD. Etomoxir-induced PPARalpha-modulated enzymes protect during acute renal failure. Am J Physiol Renal Physiol 2000 278 : F667 75.
21. Li S, Gokden N, Okusa MD, Bhatt R, Portilla D. Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF. Am J Physiol Renal Physiol 2005 289 : F469 80.
22. Saga D, Sakatsume M, Ogawa A et al. Bezafibrate suppresses rat antiglomerular basement membrane crescentic glomerulonephritis. Kidney Int 2005 67 : 1821 9.
23. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986 136 : 2348 57.
24. Kist-van Holthe JE, Gasser M, Womer K et al. Regulatory functions of alloreactive Th2 clones in human renal transplant recipients. Kidney Int 2002 62 : 627 31.
25. Tipping PG, Kitching AR, Huang XR, Mutch DA, Holdsworth SR. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur J Immunol 1997 27 : 530 7.
26. Tam FW, Smith J, Karkar AM, Pusey CD, Rees AJ. Interleukin-4 ameliorates experimental glomerulonephritis and up-regulates glomerular gene expression of IL-1 decoy receptor. Kidney Int 1997 52 : 1224 31.
27. Kluth DC, Ainslie CV, Pearce WP et al. Macrophages transfected with adenovirus to express IL-4 reduce inflammation in experimental glomerulonephritis. J Immunol 2001 166 : 4728 36.
28. Holdsworth SR, Kitching AR, Tipping PG. Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int 1999 55 : 1198 216.
29. Lovett-Racke AE, Hussain RZ, Northrop S et al. Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease. J Immunol 2004 172 : 5790 8.
30. Enioutina EY, Visic VD, Daynes RA. Enhancement of common mucosal immunity in aged mice following their supplementation with various antioxidants. Vaccine 2000 18 : 2381 93.
31. Poynter ME, Daynes RA. Age-associated alterations in splenic iNOS regulation: influence of constitutively expressed IFN-gamma and correction following supplementation with PPARalpha activators or vitamin E. Cell Immunol 1999 195 : 127 36.
32. Tesch GH, Schwarting A, Kinoshita K, Lan HY, Rollins BJ, Kelley VR. Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest 1999 103 : 73 80.
33. Tesch GH, Maifert S, Schwarting A, Rollins BJ, Kelley VR. Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas (lpr) mice. J Exp Med 1999 190 : 1813 24.
34. Okada H, Moriwaki K, Kalluri R et al. Inhibition of monocyte chemoattractant protein-1 expression in tubular epithelium attenuates tubulointerstitial alteration in rat Goodpasture syndrome. Kidney Int 2000 57 : 927 36.
35. Kelley VR, Rovin BH. Chemokines: therapeutic targets for autoimmune and inflammatory renal disease. Springer Semin Immunopathol 2003 24 : 411 21.
36. Perez de Lema G, Maier H, Nieto E et al. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol 2001 12 : 1369 82.
37. Ichihara S, Obata K, Yamada Y et al. Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors. J Mol Cell Cardiol 2006 41 : 318 29.
38. Delayre-Orthez C, Becker J, Guenon I et al. PPARalpha downregulates airway inflammation induced by lipopolysaccharide in the mouse. Respir Res 2005 6 : 91.
39. Saga D, Sakatsume M, Kaneko Y et al. The effect of bezafibrate in crescentic glomerulonephritis. Nephrology (Carlton) 2005 10 (Suppl. 6 A432.
40. Dragomir E, Tircol M, Manduteanu I, Voinea M, Simionescu M. Aspirin and PPAR-alpha activators inhibit monocyte chemoattractant protein-1 expression induced by high glucose concentration in human endothelial cells. Vascul Pharmacol 2006 44 : 440 9.
41. Nie M, Corbett L, Knox AJ, Pang L. Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists. J Biol Chem 2005 280 : 2550 61.
42. Lee H, Shi W, Tontonoz P et al. Role for peroxisome proliferator- activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ Res 2000 87 : 516 21.
43. Fernandes G, Friend P, Yunis EJ, Good RA. Influence of dietary restriction on immunologic function and renal disease in (NZB × NZW) F1 mice. Proc Natl Acad Sci USA 1978 75 : 1500 4.
44. Friend PS, Fernandes G, Good RA, Michael AF, Yunis EJ. Dietary restrictions early and late: effects on the nephropathy of the NZB × NZW mouse. Lab Invest 1978 38 : 629 32.
45. Fernandes G, Yunis EJ, Miranda M, Smith J, Good RA. Nutritional inhibition of genetically determined renal disease and autoimmunity with prolongation of life in kdkd mice. Proc Natl Acad Sci USA 1978 75 : 2888 92.
46. Neugarten J, Feiner HD, Schacht RG, Baldwin DS. Amelioration of experimental glomerulonephritis by dietary protein restriction. Kidney Int 1983 24 : 595 601.
47. Selim E, Frkanec JT, Cunard R. Fibrates upregulate TRB3 in lymphocytes independent of PPARalpha by augmenting CCAAT/enhancer-binding proteinbeta (C/EBPbeta) expression. Mol Immunol 2007 44 : 1218 29.
48. Du K, Herzig S, Kulkarni RN, Montminy M. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 2003 300 : 1574 7.
49. Qi L, Heredia JE, Altarejos JY et al. TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism. Science 2006 312 : 1763 6.
50. Park CW, Zhang Y, Zhang X et al. PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice. Kidney Int 2006 69 : 1511 17.
51. Sivarajah A, Chatterjee PK, Hattori Y et al. Agonists of peroxisome-proliferator activated receptor-alpha (clofibrate and WY14643) reduce renal ischemia/reperfusion injury in the rat. Med Sci Monit 2002 8 : BR532 9.
52. Calkin AC, Giunti S, Jandeleit-Dahm KA, Allen TJ, Cooper ME, Thomas MC. PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse. Nephrol Dial Transplant 2006 21 : 2399 405.